Shahad Alsadik

1PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Nov 18, 2022
Single centre retrospective review of outcome of 177 Lu-DOTATATE peptide receptor radionuclide therapy in the treatment of progressive metastatic neuroendocrine tumours: Survival, toxicity, and prognostic factors.

Shahad Alsadik, Gopinath Gnanasegaran, Luohai Chen

Pageof 1

Frequent Collaborators

1 joint publications

Shaunak Navalkissoor